Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The IsraelIRLCF -13.45%65 Altman Z-Score is 1.24 as of Jul. 20, 2026, which is 7% below its 10-year median of 1.34. GuruFocus rates IRLCF with a GF Score™ of 65/100 and a GF Value™ of $273.43. The stock has 5 warning signs investors should review. Among 1,562 Chemicals companies, The Israel ranks worse than 85.92% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 1.24 is in distress zone. This implies bankruptcy possibility in the next two years.
The Israel has a Altman Z-Score of 1.24, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for The Israel's Altman Z-Score or its related term are showing as below:
IRLCF'
s Altman Z-Score Range Over the Past 10 Years
Min: 0.79 Med: 1.34 Max: 2.46
Current: 1.24
During the past 13 years, The Israel's highest Altman Z-Score was 2.46. The lowest was 0.79. And the median was 1.34.
The Israel (OTCPK:IRLCF) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
The Israel Altman Z-Score Related Terms
The Israel Altman Z-Score Historical Data
* Premium members only.
The historical data trend for The Israel's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, The Israel's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Israel Altman Z-Score vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, The Israel's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where The Israel's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The Israel's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.1205
+
1.4
*
0.1916
+
3.3
*
0.0459
+
0.6
*
0.2668
+
1.0
*
0.5206
=
1.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
The Israel (IRLCF) has a Altman Z-Score of 1.24 as of Jul. 20, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on The Israel and its competitors. This is near median its historical median of 1.34. Over the past decade, The Israel's Altman Z-Score has ranged from 0.79 to 2.46. According to the industry distribution chart, The Israel ranks #1342 out of 1562 companies in the Chemicals industry, placing it in the top 85.9%.
Is The Israel's Altman Z-Score too high?
The Israel's current Altman Z-Score of 1.24 is near median its 10-year median of 1.34. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 2.46. The Chemicals industry median Altman Z-Score is 3.06. The Israel's value of 1.24 is 59.5% below this industry median. Based on the distribution chart, The Israel ranks #1342 out of 1562 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, The Israel has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does The Israel's Altman Z-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, The Israel ranks #1342 out of 1562 companies for Altman Z-Score. This places The Israel in the lower half of its industry. The industry median Altman Z-Score is 3.06. The Israel's value of 1.24 is 59.5% below this benchmark. Historically, The Israel's own Altman Z-Score has ranged from 0.79 to 2.46 over the past decade. While the company's 10-year median is 1.34 vs. the industry median of 3.06, The Israel has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Chemicals company?
The median Altman Z-Score among Chemicals companies is 3.06, based on 1,562 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Israel's current Altman Z-Score of 1.24 is 59.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on The Israel and its competitors. For the Chemicals industry, the median Altman Z-Score is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Israel's current Altman Z-Score is 1.24, which is near median its own 10-year median of 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
The Israel (IRLCF) has a current Altman Z-Score of 1.24. The stock's GF Value™ is $273.43, compared to a current price of $238.00 — trading 13% below its estimated fair value. The current Altman Z-Score is 1.24, which is near median its 10-year median of 1.34 and 59.5% below the Chemicals industry median of 3.06. The Israel's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For The Israel (IRLCF), the current Altman Z-Score is 1.24 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Israel (IRLCF) Overvalued in 2026?
Based on GuruFocus' analysis, The Israel stock appears to be undervalued.
The current stock price of $238.00 is trading 13% below its estimated GF Value™ of $273.43.
Key valuation signals for IRLCF:
Altman Z-Score: 1.24 (near median its 10-year median of 1.34)
GF Value™: $273.43 vs. price of $238.00 (13% below fair value)
Industry Position: 59.5% below the Chemicals median (#1342 of 1562)
No single metric tells the full story. See the IRLCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
65GF Score
Get the complete analysis for IRLCF
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRLCF has been successfully added to your 
